Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,251
archived clinical trials in
Pneumonia

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Houston, TX
Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated:  2/17/2016
mi
from
Paris,
Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia
Status: Enrolling
Updated: 2/17/2016
mi
from
Paris,
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
St. Joseph's Hospital
mi
from
Hamilton,
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
St. Joseph's Hospital
mi
from
Hamilton,
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
Baylor Scott & White Health
mi
from
Temple, TX
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
Baylor Scott & White Health
mi
from
Temple, TX
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Gainesville, FL
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Chicago, IL
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Hazard, KY
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Hazard, KY
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Lexington, KY
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Boston, MA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Burlington, MA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Burlington, MA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Springfield, MA
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Detroit, MI
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
St. Louis, MO
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Omaha, NE
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Knoxville, TN
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
El Paso, TX
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
Clinical Research Facility
mi
from
Houston, TX
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated:  3/11/2016
mi
from
Limoges,
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
Status: Enrolling
Updated: 3/11/2016
mi
from
Limoges,
Click here to add this to my saved trials
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP)
Status: Enrolling
Updated:  3/14/2016
Sparrow Hospital
mi
from
Lansing, MI
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP)
Status: Enrolling
Updated: 3/14/2016
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
University of California, San Diego
mi
from
San Diego, CA
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
West Suburban Hospital
mi
from
Oak Park, IL
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
West Suburban Hospital
mi
from
Oak Park, IL
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
Mayo Clinic Foundation
mi
from
Rochester, MN
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
Mayo Clinic Foundation
mi
from
Rochester, MN
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
Audie Murphy VA Medical Center & University Hospital
mi
from
San Antonio, TX
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
Audie Murphy VA Medical Center & University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Emory Vaccine Center - The Hope Clinic
mi
from
Decatur, GA
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Emory Vaccine Center - The Hope Clinic
mi
from
Decatur, GA
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Saint Louis University - Center for Vaccine Development
mi
from
Saint Louis, MO
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Saint Louis University - Center for Vaccine Development
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Cincinnati Children's Hospital Medical Center - Infectious Diseases
mi
from
Cincinnati, OH
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Cincinnati Children's Hospital Medical Center - Infectious Diseases
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center
mi
from
Nashville, TN
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated:  4/7/2016
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
mi
from
Seattle, WA
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Status: Enrolling
Updated: 4/7/2016
Group Health Research Institute - Seattle - Vaccines and Infectious Diseases
mi
from
Seattle, WA
Click here to add this to my saved trials
Immune Suppression and Ventilator Associated Pneumonias
Immune Suppression and Ventilator Associated Pneumonias
Status: Enrolling
Updated:  4/8/2016
Ohio State University
mi
from
Columbus, OH
Immune Suppression and Ventilator Associated Pneumonias
Immune Suppression and Ventilator Associated Pneumonias
Status: Enrolling
Updated: 4/8/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
University of Louisville
mi
from
Louisville, KY
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Johns Hopkins
mi
from
Baltimore, MD
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Beth Israel
mi
from
New York, NY
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Beth Israel
mi
from
New York, NY
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Summa Health System
mi
from
Akron, OH
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Summa Health System
mi
from
Akron, OH
Click here to add this to my saved trials
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated:  4/18/2016
Baylor College of Medicine
mi
from
Houston, TX
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia
Status: Enrolling
Updated: 4/18/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
Phoenix VA Health Care System Carl T. Hayden VA Medical Center, Phoenix, AZ
mi
from
Phoenix, AZ
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
Phoenix VA Health Care System Carl T. Hayden VA Medical Center, Phoenix, AZ
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA Loma Linda Healthcare System, Loma Linda, CA
mi
from
Loma Linda, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA Loma Linda Healthcare System, Loma Linda, CA
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA Long Beach Healthcare System, Long Beach, CA
mi
from
Long Beach, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA Long Beach Healthcare System, Long Beach, CA
mi
from
Long Beach, CA
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated:  5/5/2016
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Extended Steroid in CAP(e)
CSP #574 - Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans With Severe Community-Acquired Pneumonia
Status: Enrolling
Updated: 5/5/2016
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials